Overview

A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

Status:
COMPLETED
Trial end date:
2024-06-28
Target enrollment:
Participant gender:
Summary
This is a study of a drug-drug interaction between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin
Phase:
PHASE1
Details
Lead Sponsor:
Hangzhou Sciwind Biosciences Co., Ltd.
Treatments:
Digoxin
Metformin
Rosuvastatin Calcium
Warfarin